Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;24(2):e16703.
doi: 10.1111/jocd.16703. Epub 2024 Dec 2.

Efficacy of a Postbiotic Formulation Combined With Microneedling for Mild-to-Moderate Acne: A Self-Control Study

Affiliations

Efficacy of a Postbiotic Formulation Combined With Microneedling for Mild-to-Moderate Acne: A Self-Control Study

Zhanhong Li et al. J Cosmet Dermatol. 2025 Feb.

Abstract

Background: Acne vulgaris significantly affects young individuals globally, with its onset associated with an increased prevalence of C acnes, a naturally occurring skin bacterium. In light of the rising concerns regarding antibiotic resistance and the potential for adverse effects, pharmacological interventions may not consistently represent the most suitable option. Nonpharmacological approaches, such as microneedling, offer promising alternative treatment modalities. Furthermore, the integration of postbiotics in skincare formulations for acne management has gained traction recently. Nonetheless, there remains a lack of sufficient evidence to establish the efficacy and safety of postbiotics when combined with microneedling.

Objective: To assess the clinical effectiveness of a postbiotic formulation combined with microneedling in mild-to-moderate facial acne vulgaris.

Methods: Twenty Chinese patients were enrolled, all received one treatment and were monitored 4 weeks posttreatment. The evaluation assessed symptom improvement, treatment safety, and patient satisfaction.

Results: The global acne grading system (GAGS) score decreased more than half based on the baseline. Clinical photographs following treatment revealed improved the skin lesions and brightened skin tone. Statistics from VISIA showed excellent improvement in speckle, pore, red region, and porphyrin. No significant adverse reactions have been reported during the treatment period. Additionally, more than 85% were very satisfied or satisfied with the outcome.

Conclusion: Our results showed that the postbiotic formulation combined with microneedling may benefit the restoration of the skin barrier and the equilibrium of skin microbiota. This approach may help mitigate inflammation and address skin lesions, presenting a promising therapeutic avenue for the prevention and management of acne vulgaris.

Keywords: acne vulgaris; microneedling; postbiotics; skin barrier; skin microbiota.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Treatment of EVE‐CHARM antiacne lotion with microneedling improved acne. (A) The GAGS score from baseline and 4 weeks after combined treatment with EVE‐CHARM antiacne lotion and microneedling. (B) Analysis results of improvement effects. **p <  0.01 compared with BL. 4 W, 4 weeks; BL, baseline.
FIGURE 2
FIGURE 2
Representative photos before and after treatment. This 23‐year‐old male patient has experienced acne vulgaris since his adolescent years. After one combined treatment with microneedling and EVE‐CHARM antiacne lotion, lesions were improved on Week 4. BL, baseline; 4 W, week 4.
FIGURE 3
FIGURE 3
Representative photographs of before and after treatment comparisons recorded in the VISIA imager from speckle, pore, red region, and porphyrin items. BL, baseline; 4 W, week 4.
FIGURE 4
FIGURE 4
Mean score of speckle, pore, red region, and porphyrin recorded in VISIA imager. *p <  0.05, **p <  0.01 compared with BL. BL, baseline; 4 W, week 4.
FIGURE 5
FIGURE 5
Proportion of patient satisfaction levels at the conclusion of Week 4.

Similar articles

References

    1. Kutlu Ö., Karadağ A. S., and Wollina U., “Adult Acne Versus Adolescent Acne: A Narrative Review With a Focus on Epidemiology to Treatment,” Anais Brasileiros de Dermatologia 98, no. 1 (2023): 75–83. - PMC - PubMed
    1. Layton A. M. and Ravenscroft J., “Adolescent Acne Vulgaris: Current and Emerging Treatments,” Lancet. Child & Adolescent Health 7, no. 2 (2023): 136–144. - PubMed
    1. Moradi Tuchayi S., Makrantonaki E., Ganceviciene R., Dessinioti C., Feldman S. R., and Zouboulis C. C., “Acne Vulgaris,” Nature Reviews Disease Primers 1 (2015): 15029. - PubMed
    1. Kurokawa I., Layton A. M., and Ogawa R., “Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis,” Dermatologic Therapy 11, no. 4 (2021): 1129–1139. - PMC - PubMed
    1. Eichenfield D. Z., Sprague J., and Eichenfield L. F., “Management of Acne Vulgaris: A Review,” Journal of the American Medical Association 326, no. 20 (2021): 2055–2067. - PubMed

MeSH terms